Revenue: The sum of all revenue fields included for a company's operating activities.
Sangamo Therapeutics, Inc. (SGMO) had Revenue of $18.31M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$18.31M |
$-19.99M |
|
-- |
|
$18.31M |
|
$36.16M |
|
$-17.86M |
|
$-2.10M |
|
$-19.96M |
|
$-19.96M |
|
$-19.99M |
|
$-19.99M |
|
$-19.99M |
|
$-19.99M |
|
$-17.86M |
|
$-15.96M |
|
256.95M |
|
256.95M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$49.89M |
|
$15.73M |
|
$47.66M |
|
$97.56M |
|
$47.66M |
|
-- |
|
$30.30M |
|
$77.96M |
|
$19.60M |
|
$19.60M |
|
$19.60M |
|
272.80M |
|
| Cash Flow Statement Financials | |
$-44.31M |
|
$-0.02M |
|
$36.75M |
|
$43.42M |
|
$39.84M |
|
$-3.57M |
|
$4.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-97.54% |
|
-97.54% |
|
-- |
|
-109.03% |
|
-109.18% |
|
$-44.33M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
-- |
|
49.21 |
|
1.83 |
|
-101.96% |
|
-101.96% |
|
-20.49% |
|
-101.96% |
|
$0.07 |
|
$-0.17 |
|
$-0.17 |
|